Agrasar Diagnostic & Healthcare Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 25-12-2024
- Paid Up Capital ₹ 0.20 M
as on 25-12-2024
- Company Age 11 Year, 30 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.98 Cr
as on 25-12-2024
- Revenue 52.92%
(FY 2021)
- Profit 527.91%
(FY 2021)
- Ebitda 70.73%
(FY 2021)
- Net Worth 299.02%
(FY 2021)
- Total Assets 22.78%
(FY 2021)
About Agrasar Diagnostic & Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹3.98 Cr.
Shruti Malvi, Asha Malvi, and Sharvan Malvi serve as directors at the Company.
- CIN/LLPIN
U85100MP2013PTC031936
- Company No.
031936
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Hoshangabad, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Agrasar Diagnostic & Healthcare?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shruti Malvi  | Director | 11-Dec-2013 | Current |
| Asha Malvi | Director | 04-Apr-2023 | Current |
| Sharvan Malvi | Director | 11-Dec-2013 | Current |
Financial Performance of Agrasar Diagnostic & Healthcare.
Agrasar Diagnostic & Healthcare Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 52.92% increase. The company also saw a substantial improvement in profitability, with a 527.91% increase in profit. The company's net worth Soared by an impressive increase of 299.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Agrasar Diagnostic & Healthcare?
In 2021, Agrasar Diagnostic & Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kamlabai Premnarayan Malvi Hospital Private LimitedActive 14 years 3 daysShruti Malvi, Asha Malvi and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Oct 2023 | ₹1.10 Cr | Open |
Others Creation Date: 31 Mar 2021 | ₹4.15 M | Open |
Hdfc Bank Limited Creation Date: 18 Oct 2019 | ₹1.05 M | Open |
How Many Employees Work at Agrasar Diagnostic & Healthcare?
Agrasar Diagnostic & Healthcare has a workforce of 15 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Agrasar Diagnostic & Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Agrasar Diagnostic & Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
